Tilray | TRLY - Stock


Tilray reported $282.79M in Stock for its fiscal quarter ending in June of 2025.





Stock Change Date
Akebia Therapeutics USD 13.02M 22K Jun/2026
Aurora Cannabis CAD 175.08M 55.48M Mar/2026
Avita Medical AUD 6.93M 614K Dec/2025
Canopy Growth CAD 110.51M 4.96M Mar/2026
Cronos Group USD 52.7M 4.02M Jun/2026
Divis Laboratories Ltd INR 39.54B 7.18B Mar/2026
Ionis Pharmaceuticals USD 50.83M 45.28M Jun/2026
Knight Therapeutics CAD 95.4M 2.91M Mar/2024
Moderna USD 280M 134M Jun/2026
Organigram Holdings CAD 135.16M 2.45M Mar/2026
Organon & Co USD 1.37B 33M Mar/2026
Revvity USD 378.5M 9M Jun/2026
Tilray USD 282.79M 11.9M Jun/2025
Viatris USD 3.93B 6.2M Jun/2026
Xeris Pharmaceuticals USD 80.93M 6.7M Jun/2026
Zealand Pharma A/S 10.7M 9.9M Dec/2024